美国银屑病关节炎患者合并症的真实世界负担
基于Truven Health Analytics MarketScan数据库的观察性回顾性分析,纳入2008年7月1日至2015年7月31日期间有至少两次银屑病关节炎医疗索赔的94 302例美国成人患者,评估28种合并症的患病率和发病率。最常见的合并症为高脂血症(患病率47.5%、发病率35.0%)、高血压(47.3%、31.3%)、抑郁(21.2%、15.4%)、2型糖尿病(20.2%、13.5%)和纤维肌痛(16.6%、12.4%)。银屑病关节炎患者葡萄膜炎、纤维肌痛、骨质疏松、克罗恩病和非酒精性肝病的发病率明显高于银屑病患者。
要点
- 高脂血症患病率47.5%、发病率35.0%,高血压患病率47.3%、发病率31.3%。
- 抑郁患病率21.2%、发病率15.4%,2型糖尿病患病率20.2%、发病率13.5%。
- 纤维肌痛患病率16.6%、发病率12.4%;葡萄膜炎等发病率高于银屑病患者。
核心结论
- 该观察性回顾性分析利用MarketScan数据库提供了美国大型银屑病关节炎患者人群合并症患病率和发病率的真实世界医疗索赔数据。
- 观察到的高心血管代谢合并症率与文献报道一致,可能有助于医疗保健提供者对银屑病关节炎患者进行综合管理。
研究设计与样本
- 利用Truven Health Analytics MarketScan数据库开展的观察性回顾性分析。
- 纳入2008年7月1日至2015年7月31日期间诊断为银屑病关节炎且有两次或以上银屑病关节炎医疗索赔的美国成人患者。
- 共186 552例患者诊断为银屑病关节炎,其中94 302例有两次或以上医疗索赔并纳入合并症分析。
- 评估28种合并症的患病率和发病率,并与既往发表的银屑病患者类似分析结果进行比较。
主要发现
- 高脂血症患病率47.5%、发病率35.0%;高血压患病率47.3%、发病率31.3%。
- 抑郁患病率21.2%、发病率15.4%;2型糖尿病患病率20.2%、发病率13.5%;纤维肌痛患病率16.6%、发病率12.4%。
- 银屑病关节炎患者葡萄膜炎、纤维肌痛、骨质疏松、克罗恩病和非酒精性肝病的发病率明显高于银屑病患者。
关键数值与推荐
- 高脂血症患病率47.5%、发病率35.0%。
- 高血压患病率47.3%、发病率31.3%。
- 抑郁患病率21.2%、发病率15.4%。
- 2型糖尿病患病率20.2%、发病率13.5%。
- 纤维肌痛患病率16.6%、发病率12.4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We assessed comorbidities associated with psoriatic arthritis in a broad cohort of US-insured adult patients using the Truven Health Analytics MarketScan Database. METHODS: Prevalence and incidence rates were assessed for 28 comorbid conditions among adult patients in the MarketScan database with a diagnosis of psoriatic arthritis and having two or more health claims for psoriatic arthritis between 1 July 2008 and 31 July 2015. Findings were compared with those of a similar, previously published analysis of patients with psoriasis. RESULTS: Among a total of 186 552 patients with a diagnosis of psoriatic arthritis, 94 302 had two or more health claims for psoriatic arthritis during the study period and were included in the comorbidity analysis. The prevalence and incidence rates of the most common comorbidities were 47.5% and 35.0% for hyperlipidaemia, respectively; 47.3% and 31.3% for hypertension; 21.2% and 15.4% for depression; 20.2% and 13.5% for type 2 diabetes mellitus; and 16.6% and 12.4% for fibromyalgia. Patients with psoriatic arthritis had notably higher incidence rates of uveitis, fibromyalgia, osteoporosis, Crohn's disease and non-alcoholic liver disease than patients with psoriasis. CONCLUSION: This observational retrospective analysis using the MarketScan database provides real-world health claims data on the prevalence and incidence of comorbidities in a large US patient population with psoriatic arthritis. The observed high cardiometabolic comorbidity rates align with those reported in the literature and may help healthcare providers in the comprehensive management of patients with psoriatic arthritis.
引用
- Shah K, Paris M, Mellars L, et al. Real-world burden of comorbidities in US patients with psoriatic arthritis. RMD Open. 2017. PMID: 29435363. doi:10.1136/rmdopen-2017-000588
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。